Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 434 results for "erbitux"

Merck KGaA, Darmstadt, Germany to Present New Research Focused...

/PRNewswire/ -- Not intended for UK-based media ESMO Abstract # Avelumab : 777PD, 7775PD, 1154P, 842TiP, 844TiP; Erbitux : 527P, 491P, 967P, 994P; Tepotinib : 1257P, 1287TiP, 1292TiP Merck KGaA, Darmstadt, Germany, to feature new research ... Yahoo! Finance, 2 days ago
[x]  

4 images for erbitux

Pharmafile, 2 months ago
Nasdaq, 3 months ago
European Pharmaceutical Manufacturer, 3 months ago
Nasdaq, 5 months ago

Update of Erbitux metastatic colorectal cancer labelling to patients with RAS wild-type tumours

Merck Serono, the biopharmaceutical division of Merck, has announced that the European Commission has approved the Type II variation to amend the Erbitux® (cetuximab) product information, updating the indication for Erbitux to the treatment of ...
 Hospital Pharmacy Europe1 month ago
24/7 Wall St

SunTrust Has Large Cap Dividend Pharma Stocks to Buy Now

Source: ThinkstockDespite the political uproar over some pharmaceutical pricing, the fact of the matter is that once the political cycle is over, it's entirely possible a lot of the rhetoric and hyperbole will die down. Politicians love to pick on ...
 24/7 Wall St4 hours ago 4 Safe Large Cap Dividend Stocks to Buy as Market Risk Increases  24/7 Wall St2 weeks ago Top Analyst Thinks Big Pharmaceutical Stocks Will Outperform the Rest of 2016  24/7 Wall St2 months ago
SleekMoney

Equities Research Analysts Upgrades for September, 27th (ABAX, ALLE, ALXN, ANDE, BJRI, CAKE, CHKP, CNMD, COF, CPLA)

Equities Research Analysts upgrades for Tuesday, September 27th: Abaxis (NASDAQ:ABAX) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, We are impressed with the strong cash position of ...
 SleekMoney2 days ago Eli Lilly and Co. (LLY) Upgraded at Zacks Investment Research  WKRB News2 days ago Eli Lilly and Co. (LLY) Lifted to Buy at Zacks Investment Research  Zolmax News5 hours ago Eli Lilly and Co. (LLY) Upgraded to Buy at Zacks Investment Research  American Banking News2 days ago
[x]  
Pocket News Alert.com

LAMEA Oncology Market: chemotherapy to witness high demand and use in oncology centers

The Oncology or anti cancer drugs are the drugs that are often used for the treatment of the cancer patients. Some of the common cancers that are rampant currently are prostate cancer, ovarian cancer, testicular cancer, adenocarcinoma, pancreatic ...
 Before It's News3 days ago LAMEA Oncology/Anti-cancer Drugs Market: skin cancer cases expected to rise through 2021  MyNewsDesk3 days ago Monoclonal antibody drugs for cancer: How they work  MayoClinic.com3 weeks ago Dr. Meenu Walia, first DNB Medical Oncologist of India Speaks on Targeted Therapy  Pocket News Alert.com4 weeks ago

Merrill Lynch Makes a Huge Change to Prestigious US 1 Portfolio

Source: ThinkstockWith earnings for the third quarter on deck, and the fourth quarter of 2016 almost underway, many of the top companies we follow on Wall Street are making some changes to the lists of their high conviction stock picks for clients.
 24/7 Wall St2 days ago
Motley Fool

3 Reasons to Buy Array Biopharma

Image source: Array BioPharma. Array BioPharma, Inc. ( NASDAQ:ARRY ) shares are soaring recently following a slate of good news. Is there more room left to run? Read on to find out why I think if management delivers on these three catalysts, ...
 Motley Fool2 days ago Array Plays Catch-Up In Braf-Mek Derby  Seeking Alpha3 days ago
Zacks.com

Array (ARRY) Hits 52-Week High on Positive Phase III Data

Array BioPharma Inc. ARRY , along with its partner Pierre Fabre, announced positive top-line data from part 1 of the phase III study, COLUMBUS, on a combination of encorafenib (BRAF inhibitor) and binimetinib (MEK inhibitor) for the treatment of ...
 Zacks.com3 days ago
[x]  
BioPharma Dive

Amgen's Biosimilar of Abbvie's Humira Gets FDA Approval

Amgen, Inc. AMGN today announced the approval of Amjevita (adalimumab-atto), a biosimilar version to AbbVie Inc.'s ABBV rheumatoid arthritis (RA) drug Humira. Amjevita has been approved for the same indications that Humira is being used for ...
 Yahoo! Singapore4 days ago Amgen scores first Humira biosimilar approval  BioPharma Dive4 days ago Amgen's Humira biosim, Amjevita, passes FDA milestone on long road to market  FiercePharma6 days ago AbbVie smacks Amgen with a patent suit over Humira biosim  FiercePharma1 month ago
[x]  

Personalized medicine

Upcoming SlideShare Loading in … 5 1. Noelle Gillette Cloven MD Gynecologic Oncologist Texas Oncology 2. A Tale of Two Women 3. What is personalized medicine?  treatment tailored to unique characteristics of an individual person  ...
 SlideShare.net5 days ago Bristol-Myers Squibb Appoints Fouad Namouni, M.D., Oncology Development Head  Pharmacy Choice1 month ago Merck Lifts Forecast Following Good Second Quarter  Bionity.com1 month ago Bristol-Myers Squibb Reports Second Quarter Financial Results  Wallstreet Online2 months ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - erbitux
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less